GSK (NYSE:GSK) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.68, beating the consensus estimate of $0.64 by $0.04 per share. Revenue came in at $11.5B, beating the estimate of $11.2B.
GSK's stock moved following the earnings release. The stock currently trades at $59.17 with a market capitalization of $99.4B.